Global Health Limited

NSE MEDANTA.NS

Global Health Limited EBITDA for the year ending March 31, 2024: USD 104.52 M

Global Health Limited EBITDA is USD 104.52 M for the year ending March 31, 2024, a 26.69% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Global Health Limited EBITDA for the year ending March 31, 2023 was USD 82.50 M, a 30.69% change year over year.
Global Health Limited EBITDA for the year ending March 31, 2022 was USD 63.13 M, a 102.45% change year over year.
Global Health Limited EBITDA for the year ending March 31, 2021 was USD 31.18 M, a -0.22% change year over year.
Global Health Limited EBITDA for the year ending March 31, 2020 was USD 31.25 M, a -2.41% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NSE: MEDANTA.NS

Global Health Limited

CEO	Mr. Pankaj Prakash Sahni
IPO Date	Nov. 18, 2022
Location	India
Headquarters	The Medicity
Employees	9,052
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals Telehealth

Description

Global Health Limited, a multi-specialty tertiary care provider, offers healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. It operates a network of four hospitals in Gurugram, Indore, Ranchi, and Lucknow under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurgaon, India.

Key trends

Past 5 years